BiochemistrybioRxivPreprint
Tumor Immune Cell Targeting Chimeras (TICTACs) reprogram tumor-associated macrophages
M. Morimoto, D. S. Roberts, R. Wen…·C. R. Bertozzi
The paper develops TICTACs, which selectively target and degrade checkpoint receptors on tumor-associated macrophages without affecting other cells.
DOI 10.1101/2023.12.06.570444